TY - JOUR
T1 - Reinforcement Learning Models and Algorithms for Diabetes Management
AU - Yau, Kok-Lim Alvin
AU - Chong, Yung-Wey
AU - Fan, Xiumei
AU - Wu, Celimuge
AU - Saleem, Yasir
AU - Lim, Phei-Ching
N1 - Publisher Copyright:
© 2013 IEEE.
PY - 2023/3/24
Y1 - 2023/3/24
N2 - With the advancements in reinforcement learning (RL), new variants of this artificial intelligence approach have been introduced in the literature. This has led to increased interest in using RL to address complex issues in diabetes management. Using RL, a decision maker (or agent) observes decision-making factors (or state) from the dynamic operating environment, selects actions, and subsequently receives delayed rewards. The agent adapts its actions to changes in the operating environment to maximize its cumulative reward and improve system performance. This paper presents how various variants of RL have been used to improve diabetes management, such as a higher time in range during which the blood glucose level is within the normal range and a higher similarity between RL and physician's policies. Key highlights focus on the application of RL in diabetes management, including a taxonomy of the attributes of RL (e.g., roles and advantages), essential elements for training (e.g., data and simulators), representations of diabetes attributes in RL models, and variants of RL algorithms. In addition, this paper discusses open issues and potential future developments in the use of RL in diabetes management.
AB - With the advancements in reinforcement learning (RL), new variants of this artificial intelligence approach have been introduced in the literature. This has led to increased interest in using RL to address complex issues in diabetes management. Using RL, a decision maker (or agent) observes decision-making factors (or state) from the dynamic operating environment, selects actions, and subsequently receives delayed rewards. The agent adapts its actions to changes in the operating environment to maximize its cumulative reward and improve system performance. This paper presents how various variants of RL have been used to improve diabetes management, such as a higher time in range during which the blood glucose level is within the normal range and a higher similarity between RL and physician's policies. Key highlights focus on the application of RL in diabetes management, including a taxonomy of the attributes of RL (e.g., roles and advantages), essential elements for training (e.g., data and simulators), representations of diabetes attributes in RL models, and variants of RL algorithms. In addition, this paper discusses open issues and potential future developments in the use of RL in diabetes management.
KW - Actor-critic reinforcement learning
KW - applied reinforcement learning
KW - deep Q-network
KW - deep reinforcement learning
KW - diabetes
KW - Markov decision process
KW - multi-agent reinforcement learning
KW - reinforcement learning
KW - Q-learning
KW - Reinforcement learning
KW - Glucose
KW - Insulin
KW - Blood
KW - Deep learning
KW - Data models
KW - Diabetes
KW - Multi-agent systems
UR - http://www.scopus.com/inward/record.url?scp=85151546105&partnerID=8YFLogxK
U2 - 10.1109/ACCESS.2023.3259425
DO - 10.1109/ACCESS.2023.3259425
M3 - Review article
AN - SCOPUS:85151546105
SN - 2169-3536
VL - 11
SP - 28391
EP - 28415
JO - IEEE Access
JF - IEEE Access
ER -